NCT02241629View on ClinicalTrials.gov

Levo Phencynonate Hydrochloride for the Prevention of Seasickness

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Motion Sickness
Interventions
DRUG

placebo

placebo of levo phencynonate hydrochloride

DRUG

levo phencynonate hydrochloride

levo phencynonate hydrochloride

Trial Locations (1)

Unknown

Qingdao municipal hospital, Qingdao

All Listed Sponsors
lead

Sihuan Pharmaceutical Holdings Group Ltd.

INDUSTRY

NCT02241629 - Levo Phencynonate Hydrochloride for the Prevention of Seasickness | Biotech Hunter | Biotech Hunter